-
Featured
Identifying Risk Factors for Type 2 Myocardial Infarction
In one of the first large systematic surveys of the frequency and implications of supply/demand-related Type 2 Myocardial Infarction, a suite of risk factors has been identified to help ensure patients receive proper care.
-
Featured
Novel Therapeutic May Prevent Mitral Valve Damage After Heart Attack
Damage to the mitral valve after heart attack leads to HF and death. Treatment with hypertension drug may reduce mitral valve scaring and stiffening.
-
Featured
DNA is not Destiny When it Comes to Heart Attack Risk
A study led by Sekar Kathiresan, MD, of Mass General, has found that having a favorable lifestyle can help those with a high genetic risk of having a heart attack reduce their risk by over 50%.
-
Use of High-sensitivity Cardiac Troponin Assays Would Benefit U.S. Hospitals
As of September 2021, only 33% of U.S. hospitals used high-sensitivity cardiac troponin assays, Massachusetts General Hospital researchers found. Yet, the assays are linked to modestly shorter length of stay, no increase in in-hospital mortality, and less use of invasive angiography to evaluate low-risk chest pain.
-
Q&A: AI Predicts 10-Year Risk of Heart Attack and Stroke from X-Ray Images
Michael Lu, MD, MPH, Vineet Raghu, PhD, and colleagues have developed a deep learning model that can predict the 10-year risk of death from a heart attack or stroke using a single chest X-ray.
-
Acetylcholine Derived From B Cells May Protect Against Cardiovascular Disease
B cells in the bone marrow are an important source of acetylcholine, Massachusetts General Hospital researchers have discovered. B cell–derived acetylcholine regulated normal hematopoiesis and limited emergency hematopoiesis in cardiovascular disease by modulating signals produced by the bone marrow stromal niche.
Myocardial Infarction Contributors
-
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Review: Predicting Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction
-
James Louis Januzzi, MD
Director, Dennis and Marilyn Barry Fellowship in Cardiology Research, Cardiologist, Corrigan Minehan Heart Center, Massachusetts General Hospital, Hutter Family Professor of Medicine in the Field of Cardiology, Harvard Medical School
Recent Article
Multi-Biomarker Panel Predicts CV Events in Patients With Chronic Kidney Disease
-
Pradeep Natarajan, MD, MMSc
Director, Preventive Cardiology, Associate Professor of Medicine, Harvard Medical School
Recent Article
BP Polygenic Risk Scores May Complement Measured BP for CVD Prevention
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.